Study of the role of exhaled nitric oxide (NO) in predicting controlled or uncontrolled asthma in asthmatic children
Keywords:
Asthma, Asthma control, exhaled NO, FENO, CANOAbstract
Background: Exhaled nitric oxide (NO), especially fractional concentration of exhaled NO (FENO) has been used to predict the responsiveness of inhaled corticosteroid (ICS) in children with asthma. However, the use of exhaled NO for predicting asthma control in children is still controversial.
Methods: This was a randomized and cross-sectional study. Asthmatic children who were naïve to inhaled corticosteroid (ICS) were included in the present study. The measurements of FENO and CANO (concentration of NO in the gas phase of the alveolar), spirometry, blood eosinophil counts (BEC), and total IgE levels were done for each asthmatic child.
Results: Ninety three asthmatic children (9±3 years) with moderate (63.4%) to severe (36.6%) asthma were included and finished the 3 month study. The levels of FENO and CANO at inclusion were 37±11 ppb and 5.8±1.4 ppb, respectively; the mean of BEC was 617±258 cells/µL; the level of total IgE was 1563±576 UI/mL; 89% of subjects were positive for at least one respiratory allergen. The percentage of severe asthma was reduced significantly after 3 months (P<0.001). Well controlled asthma subjects at 3 months had higher levels of FENO and lower levels of CANO at inclusion (P<0.05 and P<0.05). FENO <20 ppb or CANO >5 ppb had a risk of uncontrolled asthma at 3 months (OR: 1.7, CI 95% [(0.8) – (3.3)], P<0.05; OR: 1.9, CI 95% [(0.9) – (2.7)], p<0.05; respectively). FENO >35 ppb at inclusion had a positive predictive value for asthma control at 3 months (OR: 3.5, CI 95% [2.2 – 5.9], P<0.01).
Conclusions: Exhaled NO is a biomarker of asthma which may have a potential role to predict the control of asthma in short-term follow-up in asthmatic children.
References
Global Initiative for Asthma. [Internet]. Archived reports. Accessed on: 29 April 2020. Available from: http://ginasthma.org/archived-reports/
Centers for Disease Control and Prevention. [Internet]. Asthma in the US vital signs. 2011. Accessed on: 29 April 2020. Available from: https://www.cdc.gov/vitalsigns/asthma/index.html
Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief 2012;1–8.
Toizumi M, Hashizume M, Nguyen HAT, Yasunami M, Kitamura N, Iwasaki C, Takegata M, Moriuchi H, Dang DA, Ariyoshi K, Yoshida LM. Asthma, rhinoconjunctivitis, eczema, and the association with perinatal anthropometric factors in Vietnamese children. Sci Rep 2019;9:2655.
Nga NN, Chai SK, Bihn TT, Redding G, Takaro T, Checkoway H, et al. ISAAC-based asthma and atopic symptoms among Ha Noi school children. Pediatr Allergy Immunol 2003;14:272-9.
Cloutier MM, Schatz M, Castro M, Clark N, Kelly HW, Mangione-Smith R, et al. Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol 2012;129:S24-33.
Nguyen-Thi-Bich H, Duong-Thi-Ly H, Thom VT, et al. Study of the correlations between fractional exhaled 359 nitric oxide in exhaled breath and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children. J Asthma Allergy 2016;9:163-70.
Dinh-Thi-Dieu H, Vo-Thi-Kim A, Tran-Van H, Tang-Thi-Thao T, Duong-Quy S. Study of the beneficial role of exhaled nitric oxide in combination with GINA guidelines for titration of inhaled corticosteroids in children with asthma. J Breath Res 2020. doi: 10.1088/1752-7163/ab6809.
Eguiluz-Gracia I, Tay TR, Hew M, Escribese MM, Barber D, O’Hehir RE, et al. Recent developments and highlights in biomarkers in allergic diseases and asthma. Allergy 2018;73:2290-305.
Fitzpatrick AM. Biomarkers of asthma and allergic airway diseases. Ann Allergy Asthma Immunol 2015;115:335-40.
Hancox RJ, Pavord ID, Sears MR. Associations between blood eosinophils and decline in lung function among adults with and without asthma. Eur Respir J 2018;51:1702536.
Konradsen JR, Skantz E, Nordlund B, Lidegran M, James A, Ono J, et al. Predicting asthma morbidity in children using proposed markers of Th2-type inflammation. Pediatr Allergy Immunol 2015;26:772-9.
Sippel JM, Holden WE, Tilles SA, O'Hollaren M, Cook J, Thukkani N, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000;106:645-50.
Ozier A, Girodet PO, Bara I, Tunon de Lara J-M, Marthan R, Berger P. Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients. Respir Med 2011;105:989-96.
Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 2008;31:539-46.
Wang Z, Pianosi P, Keogh K, Zaiem F, Alsawas M, Alahdab F, et al. The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Report No. 17(18)-EHC030-EF. AHRQ Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality (US); 2017.
Malinovschi A, Van Muylem A, Michiels S, Michils A. FeNO as a predictor of asthma control improvement after starting inhaled steroid treatment. Nitric Oxide 2014;40:110-6.
Duong-Quy S. Clinical utility of the exhaled nitric oxide (NO) measurement with portable devices in the management of allergic airway inflammation and asthma. J Asthma Allergy 2019;12:331-41.
National Institute for Health and Care Excellence (NICE). [Internet]. Asthma: diagnosis, monitoring and chronic asthma management. Accessed on: 28 April 2020. Available from: https://www.nice.org.uk/guidance/ng80/chapter/Recommendations#diagnosing-asthma-in-young-children
Scichilone N, Battaglia S, Taormina S, Modica V, Pozzecco E, Bellia V. Alveolar nitric oxide and asthma 352 control in mild untreated asthma. J Allergy Clin Immunol 2013;131:1513-7.
Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, et al. Alveolar nitric oxide in adults with asthma: Evidence of distal lung inflammation in 355 refractory asthma. Eur Respir J 2005;25:986-91.
Sardón O, Corcuera P, Aldasoro A, Korta J, Mintegui J, Emparanza JI, Pérez-Yarza EG. Alveolar nitric oxide and its role in pediatric asthma control assessment. BMC Pulm Med 2014;14:126.
Nguyen-Thi-Bich H, Duong-Thi-Ly H, Thom VT, Pham-Thi-Hong N, Doan Dinh L, Le-Thi-Minh H, et al. Study of the correlations between fractional exhaled 359 nitric oxide in exhaled breath and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children. J Asthma Allergy 2016;9:163-70.
Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol 2007;102:417-25.
Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-15.
Bobrowska-Korzeniowska M, Stelmach I, Brzozowska A, Jerzyńska J, Mitał M, Stelmach W. The effect of passive smoking on exhaled nitric oxide in asthmatic children. Nitric Oxide 2019;86:48-53.
Duong-Quy S, Hua-Huy T, Mai-Huu-Thanh B, Doan-Thi-Quynh N, Le-Quang K, Nguyen-Van H, et al. Early detection of smoking related chronic obstructive pulmonary disease in Vietnam. Rev Mal Respir 2009;26:267-74.
Akinbami LJ, Kit BK, Simon AE. Impact of environmental tobacco smoke on children with asthma, United States, 2003-2010. Acad Pediatr 2013;13:508-16.
Wang Z, May SM, Charoenlap S, Pyle R, Ott NL, Mohammed K, Joshi AY. Effects of secondhand smoke exposure on asthma morbidity and health care utilization in children: a systematic review and metaanalysis. Ann Allergy Asthma Immunol 2015;115:396-401.
Beck-Ripp J, Griese M, Arenz S, Köring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;19:1015-9.
Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-73.
Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC. Clinical patterns in asthma based on proximal and distal airway nitric oxide categories. Respir Res 2010;11:47.
Zinellu E, Piras B, Ruzittu GGM, Fois SS, Fois AG, Pirina P. Recent advances in inflammation and treatment of small airways in asthma. Int J Mol Sci 2019;20:377.
32. Paredi P, Kharitonov SA, Meah S, Barnes PJ, Usmani OS. A novel approach to partition central and peripheral airway nitric oxide. Chest 2014;145:113-9.
Dinh-Xuan AT, Annesi-Maesano I, Berger P, Chambellan A, Chanez P, Chinet T, et al. Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory Society. Rev Mal Respir 2015;32:193-215.
Published
Issue
Section
License
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
